IL220576B - Immunogenic compositions - Google Patents

Immunogenic compositions

Info

Publication number
IL220576B
IL220576B IL220576A IL22057612A IL220576B IL 220576 B IL220576 B IL 220576B IL 220576 A IL220576 A IL 220576A IL 22057612 A IL22057612 A IL 22057612A IL 220576 B IL220576 B IL 220576B
Authority
IL
Israel
Prior art keywords
immunogenic compositions
immunogenic
compositions
Prior art date
Application number
IL220576A
Other languages
English (en)
Hebrew (he)
Inventor
Gallichan Scott
Harper Kevin
Ochs-Onolemhemhen Martina
Morefield Garry
Ausar Fernando
Salha Marie-Danielle
Ljutic Belma
Original Assignee
Sanofi Pasteur Ltd
Gallichan Scott
Harper Kevin
Martina Ochs Onolemhemhen
Morefield Garry
Ausar Fernando
Marie Danielle Salha
Ljutic Belma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd, Gallichan Scott, Harper Kevin, Martina Ochs Onolemhemhen, Morefield Garry, Ausar Fernando, Marie Danielle Salha, Ljutic Belma filed Critical Sanofi Pasteur Ltd
Publication of IL220576B publication Critical patent/IL220576B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL220576A 2009-12-22 2012-06-21 Immunogenic compositions IL220576B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28923609P 2009-12-22 2009-12-22
US32566010P 2010-04-19 2010-04-19
PCT/CA2010/001977 WO2011075823A1 (en) 2009-12-22 2010-12-20 Immunogenic compositions

Publications (1)

Publication Number Publication Date
IL220576B true IL220576B (en) 2018-03-29

Family

ID=44194860

Family Applications (2)

Application Number Title Priority Date Filing Date
IL220576A IL220576B (en) 2009-12-22 2012-06-21 Immunogenic compositions
IL242592A IL242592A (en) 2009-12-22 2015-11-15 Immunogenic compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL242592A IL242592A (en) 2009-12-22 2015-11-15 Immunogenic compounds

Country Status (12)

Country Link
US (1) US20130183350A1 (cg-RX-API-DMAC7.html)
EP (1) EP2515938A4 (cg-RX-API-DMAC7.html)
JP (2) JP5894083B2 (cg-RX-API-DMAC7.html)
KR (1) KR20120107121A (cg-RX-API-DMAC7.html)
CN (1) CN102802664B (cg-RX-API-DMAC7.html)
AR (1) AR079712A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010335970B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012018343A2 (cg-RX-API-DMAC7.html)
CA (1) CA2783955A1 (cg-RX-API-DMAC7.html)
IL (2) IL220576B (cg-RX-API-DMAC7.html)
WO (1) WO2011075823A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201204628B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102939105B (zh) 2009-12-22 2016-11-16 赛诺菲巴斯德有限公司 免疫原性组合物和相关的方法
JP6046632B2 (ja) 2010-12-03 2016-12-21 サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ 肺炎球菌に対する免疫用組成物
EA201391456A1 (ru) 2011-05-17 2014-05-30 Глаксосмитклайн Байолоджикалс С.А. ВАКЦИНА ПРОТИВ Streptococcus pneumoniae
GB201218660D0 (en) 2012-10-17 2012-11-28 Glaxosmithkline Biolog Sa Immunogenic composition
JP6236086B2 (ja) * 2012-10-17 2017-11-22 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム １種以上の肺炎球菌莢膜糖類コンジュゲートとインフルエンザ菌由来のタンパク質Ｅおよび／またはＰｉｌＡを含むタンパク質成分とを含む免疫原性組成物
EP2931743A4 (en) * 2012-12-14 2016-08-03 Sanofi Pasteur Ltd METHOD FOR ASSESSING IMMUNOGENICITY
AU2015228542A1 (en) * 2014-03-10 2016-09-22 Sanofi Pasteur Limited Immunogenic compositions
KR101688960B1 (ko) * 2014-06-11 2016-12-23 전남대학교산학협력단 스쿠티카충 백신 조성물
SG11201706081SA (en) * 2015-01-27 2017-08-30 3M Innovative Properties Co Alum-containing coating formulations for microneedle vaccine patches
GB2556002B (en) * 2015-07-07 2020-12-16 Bluewillow Biologics Inc Methods and compositions for nanoemulsion vaccine formulations
EP3736574A1 (en) * 2019-05-07 2020-11-11 Atlas Antibodies AB A formulation comprising an isotope labeled fusion polypeptide
EP4395818A4 (en) * 2021-09-02 2025-08-20 Vaxcyte Inc STABILIZATION OF ADJUVANTED VACCINE COMPOSITIONS AND THEIR USE

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC2178A1 (fr) * 1988-12-16 1992-05-22 Nederlanden Staat Mutants de la pneumolysine et vaccins a base de pneumocoque prepares a partir de ces mutants
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
WO2000037105A2 (en) * 1998-12-21 2000-06-29 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0213622D0 (en) * 2002-06-13 2002-07-24 Glaxosmithkline Biolog Sa Vaccine Corporation
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
KR101916787B1 (ko) * 2005-03-23 2019-01-24 글락소스미스클라인 바이오로지칼즈 에스.에이. Ｃｄ4 ｔ－세포 및/또는 개선된 ｂ－메모리 세포 반응을 유도하는 인플루엔자 바이러스 및 수중유 에멀젼 애주번트의 용도
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
JP2010501012A (ja) * 2006-08-17 2010-01-14 ザ ユーエービー リサーチ ファウンデーション 免疫原性ＰｃｐＡポリペプチドおよびその使用
WO2009012588A1 (en) 2007-07-23 2009-01-29 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
AU2009208299B2 (en) * 2008-02-01 2015-01-22 Sanofi Pasteur Limited Assay for diagnosing streptococcus pneumoniae
CA2748149C (en) * 2008-12-24 2018-03-06 Netherlands Vaccine Institute Modified steptococcus pneumonia pneumolysin (ply) polypeptides

Also Published As

Publication number Publication date
US20130183350A1 (en) 2013-07-18
CN102802664A (zh) 2012-11-28
CN102802664B (zh) 2017-04-05
JP2016104776A (ja) 2016-06-09
AR079712A1 (es) 2012-02-15
EP2515938A1 (en) 2012-10-31
ZA201204628B (en) 2013-02-27
JP2013515015A (ja) 2013-05-02
AU2010335970A1 (en) 2012-07-05
CA2783955A1 (en) 2011-06-30
KR20120107121A (ko) 2012-09-28
BR112012018343A2 (pt) 2017-06-27
AU2010335970B2 (en) 2016-11-03
IL242592A (en) 2017-10-31
JP5894083B2 (ja) 2016-03-23
WO2011075823A1 (en) 2011-06-30
EP2515938A4 (en) 2013-08-28

Similar Documents

Publication Publication Date Title
GB0913681D0 (en) Immunogenic composition
ZA201109176B (en) Homeglobin compositions
IL217949A0 (en) Pesticdal compositions
GB0906515D0 (en) Fungical compositions
GB201003924D0 (en) Immunogenic composition
ZA201106050B (en) Dye-polymers formulations
ZA201109312B (en) Compositions
PT2402032T (pt) Composição imunogénica
GB0910046D0 (en) Novel compositions
IL242592A (en) Immunogenic compounds
IL269369A (en) The vehicles are improved
GB0919210D0 (en) Formulations
IL214127A0 (en) Vaccine compositions
GB0910045D0 (en) Novel compositions
EP2252326A4 (en) VACCINE COMPOSITIONS
EP2640418A4 (en) IMMUNOGENIC COMPOSITIONS
GB0913680D0 (en) Immunogenic composition
IL220308A0 (en) Vaccine compositions
GB0905165D0 (en) Compositions
ZA201301908B (en) Immunogenic compositions
GB0908963D0 (en) Compositions
IL217390A0 (en) Formulations
GB0900943D0 (en) Vaccine compositions
GB0905968D0 (en) Compositions
GB0913668D0 (en) Compositions

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees